Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 40.16% is 28% below its 5-year average of 55.57%, near the low end of its 5-year range (36.49%–66.40%).
As of the fiscal period ended Tuesday, June 30, 2026. 21.60% below its 12-month average of 51.23%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 40.16%.
DEBT TO ASSETS RATIO
40.16%
DEBT TO ASSETS RATIO AVG TTM
51.23%
DEBT TO ASSETS RATIO AVG 3Y
55.44%
DEBT TO ASSETS RATIO AVG 5Y
55.57%
DEBT TO ASSETS RATIO AVG 10Y
34.35%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-21.60%
CURRENT VS 3Y AVG
-27.56%
CURRENT VS 5Y AVG
-27.72%
CURRENT VS 10Y AVG
+16.91%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 595 covered companies
CURRENT VS SECTOR MEDIAN
+40062.75%
vs the sector median at left
Collegium Pharmaceutical, Inc.
Market Cap
$704.14M
Debt to Assets Ratio
40.16%
TTM Avg
51.23%
3Y Avg
55.44%
5Y Avg
55.57%
Market Cap
$711.94M
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$715.08M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$700.94M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$742.59M
Debt to Assets Ratio
0.24%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$676.27M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$745.00M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$750.11M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$753.89M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Collegium Pharmaceutical, Inc. (COLL) | $704.14M | 40.16% | 51.23% | 55.44% | 55.57% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $711.94M | 0.08% | N/A | N/A | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $715.08M | 0.00% | N/A | N/A | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $700.94M | 0.01% | N/A | N/A | N/A |
| Candel Therapeutics, Inc. (CADL)vs › | $742.59M | 0.24% | N/A | N/A | N/A |
| Faeth Therapeutics, Inc. (FTH)vs › | $676.27M | 0.00% | N/A | N/A | N/A |
| Cytek Biosciences, Inc. (CTKB)vs › | $745.00M | 0.06% | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $750.11M | 0.01% | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $753.89M | 0.03% | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $664.86M | 0.01% | N/A | N/A | N/A |
Debt/Assets
40.2%
Debt/Equity
2.75
Current Ratio
1.03
Interest Coverage
2.3x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 40.16% |
| 2026-03-31 | 48.92% |
| 2025-12-31 | 56.77% |
| 2025-09-30 | 58.25% |
| 2025-06-30 | 52.06% |
| 2025-03-31 | 51.75% |
| 2024-12-31 | 51.65% |
| 2024-09-30 | 53.47% |
| 2024-06-30 | 53.11% |
| 2024-03-31 | 56.54% |
| 2023-12-31 | 58.98% |
| 2023-09-30 | 61.01% |
| 2023-06-30 | 62.80% |
| 2023-03-31 | 66.40% |
| 2022-12-31 | 60.40% |
| 2022-09-30 | 60.96% |
| 2022-06-30 | 60.61% |
| 2022-03-31 | 62.41% |
| 2021-12-31 | 37.39% |
| 2021-09-30 | 36.49% |
| 2021-06-30 | 39.58% |
| 2021-03-31 | 45.56% |
| 2020-12-31 | 41.41% |
| 2020-09-30 | 42.98% |
| 2020-06-30 | 44.33% |
| 2020-03-31 | 46.77% |
| 2019-12-31 | 7.05% |
| 2019-09-30 | 7.19% |
| 2019-06-30 | 7.31% |
| 2019-03-31 | 7.51% |
| 2018-12-31 | 3.95% |
| 2018-09-30 | 1.78% |
| 2018-06-30 | 1.71% |
| 2018-03-31 | 1.65% |
| 2017-12-31 | 1.09% |
| 2017-09-30 | 1.75% |
| 2017-06-30 | 2.26% |
| 2017-03-31 | 2.49% |
| 2016-12-31 | 2.56% |
| 2016-09-30 | 4.88% |
| 2016-06-30 | 4.58% |
| 2016-03-31 | 4.51% |
| 2015-12-31 | 6.97% |
| 2015-09-30 | 6.99% |
| 2015-06-30 | 6.77% |
| 2015-03-31 | 16.66% |
| 2014-12-31 | 255.54% |
